Erlotinib induces the human non–small‐cell lung cancer cells apoptosis via activating ROS‐dependent JNK pathways

Although erlotinib (ERL) has drawn more and more attention toward its anticancer properties effect, the underlying mechanisms of ERL's anticancer properties effect remain unclear yet. So, the aim of this research was to explore the underlying anticancer mechanisms of ERL and to explore whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Fenglian, Shao, Zewei, Jiang, Shenghua, Cheng, Zhaozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119972/
https://www.ncbi.nlm.nih.gov/pubmed/27726288
http://dx.doi.org/10.1002/cam4.881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119972/
https://www.ncbi.nlm.nih.gov/pubmed/27726288
http://dx.doi.org/10.1002/cam4.881

Ejemplares similares